Abstract:Predicting drug–disease associations can contribute to discovering new therapeutic potentials of drugs, and providing important association information for new drug research and development. Many existing drug–disease association prediction methods have not distinguished relevant background information for the same drug targeted to different diseases. Therefore, this paper proposes a drug–disease association prediction model based on graph convolutional network and graph attention network (GCNGAT) to reposition marketed drugs under the distinguishment of background information. Firstly, in order to obtain initial drug–disease information, a drug–disease heterogeneous graph structure is constructed based on all known drug–disease associations. Secondly, based on the heterogeneous graph structure, the corresponding subgraphs of each group of drug–disease association pairs are extracted to distinguish different background information for the same drug from different diseases. Finally, a model combining Graph neural network with global Average pooling (GnnAp) is designed to predict potential drug–disease associations by learning drug–disease interaction feature representations. The experimental results show that adding subgraph extraction can effectively improve the prediction performance of the model, and the graph representation learning module can fully extract the deep features of drug–disease. Using the 5-fold cross-validation, the proposed model (GCNGAT) achieves AUC (Area Under the receiver operating characteristic Curve) values of 0.9182 and 0.9417 on the PREDICT dataset and CDataset dataset, respectively. Compared with other predictors on the same dataset (PREDICT dataset), GCNGAT outperforms the existing best-performing model (PSGCN), with a 1.58% increase in the AUC value. It is anticipated that this model can provide experimental reference for drug repositioning and further promote the drug research and development process.

Identifying Candidate Gene–Disease Associations via Graph Neural Networks

A novel interactive deep cascade spectral graph convolutional network with multi-relational graphs for disease prediction

GCN-MF: Disease-Gene Association Identification By Graph Convolutional Networks and Matrix Factorization

A knowledge graph-based disease-gene prediction system using multi-relational graph convolution networks

Towards Probabilistic Generative Models Harnessing Graph Neural Networks for Disease-Gene Prediction

Mining disease-associated genes based on heterogeneous graph transformer.

LncRNA-Disease Association Prediction Based on Graph Neural Networks and Inductive Matrix Completion

Identifying Associations between Small Nucleolar RNAs and Diseases via Graph Convolutional Network and Attention Mechanism

PGCN: Disease gene prioritization by disease and gene embedding through graph convolutional neural networks

GNN4DM: a graph neural network-based method to identify overlapping functional disease modules

Hybrid Multimodal Fusion for Graph Learning in Disease Prediction

MedGraphNet: Leveraging Multi-Relational Graph Neural Networks and Text Knowledge for Biomedical Predictions

Identifying Potential Association on Gene-Disease Network Via Dual Hypergraph Regularized Least Squares

Identifying Disease Related Genes by Network Representation and Convolutional Neural Network.

GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention network

Predicting disease-gene associations through self-supervised mutual infomax graph convolution network

Self-supervised graph representation learning integrates multiple molecular networks and decodes gene-disease relationships

End-to-end interpretable disease–gene association prediction

Integration of multi-source gene interaction networks and omics data with graph attention networks to identify novel disease genes

Predicting Disease-related RNA Associations based on Graph Convolutional Attention Network

Graph Node Classification to Predict Autism Risk in Genes